This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2024 Dec 10;150(24):1910-1912.

doi: 10.1161/CIRCULATIONAHA.124.070463. Epub 2024 Dec 9.

Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention

Andreas L Birkenfeld^{1

2

3

4}, Paul W Franks^{5

6}, Viswanathan Mohan^{7

8}

Affiliations

Affiliations

¹ Department of Diabetology, Endocrinology, and Nephrology, University Hospital Tübingen, Germany (A.L.B.).
² Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Germany (A.L.B.).
³ Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany (A.L.B.).
⁴ Department of Diabetes, Life Sciences & Medicine, Cardiovascular Medicine & Sciences, Kings College London, UK (A.L.B.).
⁵ Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden (P.W.F.).
⁶ Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA (P.W.F.).
⁷ Madras Diabetes Research Foundation, Chennai, India (V.M.).
⁸ Dr Mohan's Diabetes Specialities Centre, Chennai, India (V.M.).

PMID: 39652647
DOI: 10.1161/CIRCULATIONAHA.124.070463

Precision Medicine in People at Risk for Diabetes and Atherosclerotic Cardiovascular Disease: A Fresh Perspective on Prevention

Andreas L Birkenfeld et al. Circulation. 2024.

. 2024 Dec 10;150(24):1910-1912.

doi: 10.1161/CIRCULATIONAHA.124.070463. Epub 2024 Dec 9.

Authors

Andreas L Birkenfeld^{1

2

3

4}, Paul W Franks^{5

6}, Viswanathan Mohan^{7

8}

Affiliations

¹ Department of Diabetology, Endocrinology, and Nephrology, University Hospital Tübingen, Germany (A.L.B.).
² Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, Eberhard-Karls University Tübingen, Germany (A.L.B.).
³ Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich at the University of Tübingen, Germany (A.L.B.).
⁴ Department of Diabetes, Life Sciences & Medicine, Cardiovascular Medicine & Sciences, Kings College London, UK (A.L.B.).
⁵ Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Science, Lund University, Helsingborg, Sweden (P.W.F.).
⁶ Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA (P.W.F.).
⁷ Madras Diabetes Research Foundation, Chennai, India (V.M.).
⁸ Dr Mohan's Diabetes Specialities Centre, Chennai, India (V.M.).

PMID: 39652647
DOI: 10.1161/CIRCULATIONAHA.124.070463

No abstract available

Keywords: cardiovascular diseases; diabetes mellitus, type 2; precision medicine.

PubMed Disclaimer

Conflict of interest statement

Dr Birkenfeld received research support and served on an advisory board for NovoNordisk. The other authors do not have conflicts of interest.

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.